-
Multiomics Used To Stratify Multiple Myeloma Patients Into Affinity Groups
Bio-IT World | All new multiple myeloma patients being treated at the Tisch Cancer Institute at Mount Sinai are now being assigned to one of 12 subgroups based on shared genetic and molecular features of their disease. The multiple myeloma patient similarity network (MM-PSN) is one of the latest computational modeling tools being used here to translate clinical data into better treatment decision-making in the clinic, and the first to apply multiomics to the stratification of patients with the blood cancer.
Jan 6, 2022
-
Overlooked Impact Of Cardiometabolic Drugs On The Gut Microbiome
Bio-IT World | A large-scale study involving more than 2,000 individuals across three countries could help disentangle associations between cardiometabolic disease, the gut microbiome, and metabolic markers in the blood—and, perhaps most importantly, the potential role played by the most prescribed drug treatments.
Jan 5, 2022
-
Is Excel Holding Back Biopharmaceutical Research?
Bio-IT World | Data aggregation and consolidation are essential in biopharmaceutical development. Research teams use a wide range of analytical and sensor data from various instruments, which are often spread across multiple sites. These data streams need a common platform to allow scientists to review the data and make decisions. Excel is used to perform this consolidation in many companies, but while access to Excel is convenient, this software is the root cause of many data management problems.
Jan 3, 2022
-
Follow the Money: AI-Driven Talent Engagement, Cancer Center Funding, Maternal Health, More
Bio-IT World | AI used in talent engagement and communication and in the development of therapeutic antibodies; women’s health, maternal health, and contraceptive technologies
Dec 28, 2021
-
Top Stories of 2021: Efforts to Overcome Aging, High-Def Spatial Transcriptomics, an NIH Push to Cure HIV. And a Little More COVID
Bio-IT World | Some of our biggest stories of the year were about the promise to limit aging through epigenetic reprogramming, new inhibitors to prevent age-associated cognitive decline, and improved single-cell sequencing technologies. Of course interest in COVID-19 remained, and we went in depth on mRNA vaccines and talked digital transformation at Pfizer and GSK in this pandemic era.
Dec 27, 2021
-
PacBio’s Precision Health Partnership, NVIDIA’s Open Source SDK, More
Bio-IT World | Singular Genomics launches new benchtop sequencer, collaborations in neuropsychiatry, lactation research, skin health, chronic pain, and SARS-CoV-2 vaccines, Insilico Medicine announces first-in-human trial of an AI-developed drug. Plus new products from PerkinElmer, Thermo Fisher, Genomenon, and more.
Dec 22, 2021


